Mastering Clinical Pharmacology II is often the turning point in a medical student’s journey. While the first level introduces you to how the body handles drugs, this advanced stage dives deep into the specific clinical applications, contraindications, and the complex “drug-drug” interactions that can make or break a treatment plan. It is the bridge between understanding a chemical compound and safely prescribing it to a patient with multiple comorbidities.
Below is the exam paper download link
Past Paper On Clinical Pharmacology II For Revision
Above is the exam paper download link
Whether you are struggling with the nuances of cardiovascular drugs or the intricacies of neuro-pharmacology, the most effective way to solidify your knowledge is through active testing. To help you prepare for your upcoming assessments, we have compiled a high-impact revision guide in a Q&A format, focusing on the concepts that examiners prioritize.
Critical Revision Questions and Answers
1. What is the “Rational Prescribing” process, and why is the P-drug concept important? Rational prescribing involves a systematic approach to ensure the patient receives the right medication, at the right dose, for the right duration, and at the lowest cost. The P-drug (Personal Drug) concept encourages clinicians to pre-select a set of drugs they know well. In an exam, you might be asked to justify a choice based on efficacy, safety, suitability, and cost (the ESSC criteria).
2. How do ACE inhibitors differ from ARBs in the management of hypertension? Both target the Renin-Angiotensin-Aldosterone System (RAAS). However, ACE inhibitors prevent the conversion of Angiotensin I to Angiotensin II, which also leads to an accumulation of bradykinin (often causing a dry cough). Angiotensin II Receptor Blockers (ARBs) block the receptor itself, providing similar blood pressure control without the bradykinin-related side effect, making them a preferred alternative for patients who cannot tolerate the cough.
3. What are the key considerations when prescribing Narrow Therapeutic Index (NTI) drugs? NTI drugs, such as Digoxin, Warfarin, or Lithium, have a very small window between a therapeutic dose and a toxic one. Revision should focus on the necessity of Therapeutic Drug Monitoring (TDM). Examiners often look for your understanding of factors that can tip the balance, such as renal impairment, dehydration, or the introduction of enzyme inhibitors/inducers.
4. Describe the mechanism of action and the major risk associated with Thrombolytic therapy. Thrombolytics, like Alteplase (tPA), work by converting plasminogen to plasmin, which then breaks down fibrin clots. While life-saving in acute ischemic stroke or MI, the most significant risk is systemic hemorrhage, particularly intracranial bleeding. A common exam question involves identifying the absolute contraindications, such as recent major surgery or a history of hemorrhagic stroke.
5. Why is “Antimicrobial Stewardship” a priority in modern pharmacology? This refers to a coordinated set of strategies to improve the use of antibiotics. The goal is to ensure the best clinical outcome while minimizing the development of multidrug-resistant organisms. When answering questions on antibiotics, always consider the importance of culture and sensitivity testing and the dangers of “broad-spectrum” overuse.
Why Downloading Past Papers is Essential for Success
Pharmacology is notorious for its “trick” questions—small changes in a patient’s history that completely change the “best” drug choice. Reading a textbook can give you the facts, but past papers give you the practice. They train your brain to spot these clinical nuances and help you manage your time effectively during the actual exam.
By integrating these papers into your study routine, you move away from rote memorization and toward the clinical reasoning skills required of a professional healthcare provider.
Last updated on: March 16, 2026